Proscillaridin A induces apoptosis and inhibits the metastasis of osteosarcoma in vitro and in vivo
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 521 (4) , 880-886
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (81341078)
This publication has 22 references indexed in Scilit:
- The pharmacogenomics of osteosarcomaThe Pharmacogenomics Journal, 2016
- Metastatic osteosarcoma: a challenging multidisciplinary treatmentExpert Review of Anticancer Therapy, 2016
- Heterogeneous transport of digitalis-like compounds by P-glycoprotein in vesicular and cellular assaysToxicology in Vitro, 2016
- Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugsJournal of Enzyme Inhibition and Medicinal Chemistry, 2016
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategiesAging, 2016
- Osteosarcoma: Current Treatment and a Collaborative Pathway to SuccessJournal of Clinical Oncology, 2015
- Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450Cell Death & Disease, 2015
- Moving targets: Emerging roles for MMPs in cancer progression and metastasisMatrix Biology, 2015
- Apoptosis in cancer: from pathogenesis to treatmentJournal of Experimental & Clinical Cancer Research, 2011
- Functional and biological analysis of Bcl-xL expression in human osteosarcomaBone, 2010